CoChat

Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Significance Statement: Studies suggest that autophagy may be protective in kidney diseases, but understanding how the autophagic process is specifically altered in each disorder is important for applying it therapeutically. On the basis of the observation that autophagy in proximal tubule epithelial cells is mainly regulated by insulin, the authors used diabetic mouse models to investigate whether types 1 and 2 diabetic nephropathy differ in autophagic status. They found distinct patterns of autophagic dysregulation involved in the pathophysiology of types 1 and 2 diabetic nephropathy, with autophagy induction suppressed in the type 2 diabetic kidney (even under starvation) and basal autophagic activity enhanced in the type 1 diabetic kidney (even under fed conditions). They also provide evidence that activated autophagy protects the type 1 diabetic kidney, whereas autophagic suppression jeopardizes the kidney in type 2 diabetes. Background: Evidence of a protective role of autophagy in kidney diseases has sparked interest in autophagy as a potential therapeutic strategy. However, understanding how the autophagic process is altered in each disorder is critically important in working toward therapeutic applications. Methods: Using cultured kidney proximal tubule epithelial cells (PTECs) and diabetic mouse models, we investigated how autophagic activity differs in type 1 versus type 2 diabetic nephropathy. We explored nutrient signals regulating starvation-induced autophagy in PTECs and used autophagy-monitoring mice and PTEC-specific autophagy-deficient knockout mice to examine differences in autophagy status and autophagy’s role in PTECs in streptozotocin (STZ)-treated type 1 and db / db type 2 diabetic nephropathy. We also examined the effects of rapamycin (an inhibitor of mammalian target of rapamycin [mTOR]) on vulnerability to ischemia-reperfusion injury. Results: Administering insulin or amino acids, but not glucose, suppressed autophagy by activating mTOR signaling. In db / db mice, autophagy induction was suppressed even under starvation; in STZ-treated mice, autophagy was enhanced even under fed conditions but stagnated under starvation due to lysosomal stress. Using knockout mice with diabetes, we found that, in STZ-treated mice, activated autophagy counteracts mitochondrial damage and fibrosis in the kidneys, whereas in db / db mice, autophagic suppression jeopardizes kidney even in the autophagy-competent state. Rapamycin-induced pharmacologic autophagy produced opposite effects on ischemia-reperfusion injury in STZ-treated and db/db mice. Conclusions: Autophagic activity in PTECs is mainly regulated by insulin. Consequently, autophagic activity differs in types 1 and 2 diabetic nephropathy, which should be considered when developing strategies to treat diabetic nephropathy by modulating autophagy.

Overview

Integrity signals

Registry

Crossref · 10.1681/asn.2018100983

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 96

Metadata

Authors
Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., Matsui, I., Matsusaka, T., Niimura, F., Yanagita, M., & Isaka, Y.
Affiliations
  • The University of Osaka (JP)
  • Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan;
  • Institute of Medical Sciences (IN)
  • Tokai University (JP)
  • Kyoto University (JP)
Corresponding author
Takabatake, Yoshitsugu
Venue
Journal of the American Society of Nephrology
Published
2019-04-30
Volume
30
Issue
6
Pages
929-945
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W2942855331
Cited by
96
References
57
Citations by year
2026: 8 · 2025: 10 · 2024: 19 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 15 · 2019: 3
FWCI
7.80
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (17K16082)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords
autophagy, diabetic nephropathy, type 1 diabetes, type 2 diabetes, proximal tubular epithelial cells, mTOR signaling, insulin, starvation-induced autophagy, lysosomal stress, mitochondrial damage, renal fibrosis, ischemia-reperfusion injury, rapamycin, streptozotocin-induced diabetes, db/db mice
MeSH terms
Amino Acids, Animals, Autophagy, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Epithelial Cells, Insulin, Kidney Tubules, Proximal, Lysosomes, Mice, Inbred C57BL, Sensitivity and Specificity, Streptozocin, Mice, Knockout, Sirolimus, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.